Want to join the conversation?
On July 2, $CAH closed the purchase of The Harvard Drug Group for $1.1Bil, net of cash acquired, using existing cash and proceeds from the debt offering in June 2015. The acquisition of Harvard Drug is expected to enhance $CAH pharmaceutical segment's generic pharmaceutical distribution and services businesses.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.